<?xml version="1.0" encoding="UTF-8"?>
<ref id="B43">
 <mixed-citation publication-type="webpage">
  <person-group person-group-type="author">
   <collab>ClinicalTrials.gov</collab>
  </person-group> (
  <year>2020a</year>). 
  <source>Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARI</source>. Available online at: 
  <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT04324073?load=cart" xmlns:xlink="http://www.w3.org/1999/xlink">https://clinicaltrials.gov/ct2/show/NCT04324073?load=cart</ext-link> (accessed June 4, 2020)
 </mixed-citation>
</ref>
